• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

驱动尿路致病性多重耐药的分子因素和机制-更新。

Molecular Factors and Mechanisms Driving Multidrug Resistance in Uropathogenic -An Update.

机构信息

Department of Pediatrics, Bielanski Hospital, Ceglowska 80, 01-809 Warsaw, Poland.

Department of Cell Biology and Immunology, Centre of Postgraduate Medical Education, 01-813 Warsaw, Poland.

出版信息

Genes (Basel). 2022 Aug 6;13(8):1397. doi: 10.3390/genes13081397.

DOI:10.3390/genes13081397
PMID:36011308
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9407594/
Abstract

The rapid emergence of multidrug-resistant (MDR) bacteria indisputably constitutes a major global health problem. Pathogenic are listed among the most critical group of bacteria that require fast development of new antibiotics and innovative treatment strategies. Among harmful extraintestinal strains, uropathogenic (UPEC) pose a significant health threat. UPEC are considered the major causative factor of urinary tract infection (UTI), the second-most commonly diagnosed infectious disease in humans worldwide. UTI treatment places a substantial financial burden on healthcare systems. Most importantly, the misuse of antibiotics during treatment has caused selection of strains with the ability to acquire MDR via miscellaneous mechanisms resulting in gaining resistance against many commonly prescribed antibiotics like ampicillin, gentamicin, cotrimoxazole and quinolones. Mobile genetic elements (MGEs) such as transposons, integrons and conjugative plasmids are the major drivers in spreading resistance genes in UPEC. The co-occurrence of various bacterial evasion strategies involving MGEs and the SOS stress response system requires further research and can potentially lead to the discovery of new, much-awaited therapeutic targets. Here, we analyzed and summarized recent discoveries regarding the role, mechanisms, and perspectives of MDR in the pathogenicity of UPEC.

摘要

耐药菌(MDR)的迅速出现无疑构成了一个主要的全球健康问题。病原菌被列为最需要快速开发新抗生素和创新治疗策略的关键细菌群之一。在有害的肠道外菌株中,尿路致病性 (UPEC)构成了重大的健康威胁。UPEC 被认为是尿路感染(UTI)的主要致病因素,UTI 是全球范围内第二大常见的传染病。UTI 的治疗给医疗保健系统带来了巨大的财务负担。最重要的是,在治疗过程中抗生素的滥用导致了具有通过各种机制获得 MDR 能力的菌株的选择,从而对许多常用的抗生素(如氨苄西林、庆大霉素、复方新诺明和喹诺酮类药物)产生了耐药性。移动遗传元件(MGEs),如转座子、整合子和可移动质粒,是 UPEC 中传播耐药基因的主要驱动力。涉及 MGEs 和 SOS 应激反应系统的各种细菌逃避策略的共存需要进一步的研究,并有可能发现新的、备受期待的治疗靶点。在这里,我们分析和总结了关于 UPEC 致病性中 MDR 的作用、机制和前景的最新发现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a43/9407594/a069c50e0ae6/genes-13-01397-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a43/9407594/fae4ed8dc733/genes-13-01397-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a43/9407594/6ed240d0dc4c/genes-13-01397-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a43/9407594/c4a526434d99/genes-13-01397-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a43/9407594/a069c50e0ae6/genes-13-01397-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a43/9407594/fae4ed8dc733/genes-13-01397-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a43/9407594/6ed240d0dc4c/genes-13-01397-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a43/9407594/c4a526434d99/genes-13-01397-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1a43/9407594/a069c50e0ae6/genes-13-01397-g004.jpg

相似文献

1
Molecular Factors and Mechanisms Driving Multidrug Resistance in Uropathogenic -An Update.驱动尿路致病性多重耐药的分子因素和机制-更新。
Genes (Basel). 2022 Aug 6;13(8):1397. doi: 10.3390/genes13081397.
2
Investigation of antibiotic resistance determinants and virulence factors of uropathogenic Escherichia coli.研究尿路感染大肠杆菌的抗生素耐药决定因素和毒力因子。
J Antibiot (Tokyo). 2020 May;73(5):314-319. doi: 10.1038/s41429-020-0284-7. Epub 2020 Feb 19.
3
Study of class 1 integrons and plasmid profile among multiple drug resistant uropathogenic Escherichia coli.多重耐药性尿路致病性大肠杆菌中1类整合子与质粒图谱的研究
Pak J Pharm Sci. 2020 Nov;33(6):2643-2649.
4
A shared mechanism of multidrug resistance in laboratory-evolved uropathogenic .实验室进化的尿路致病性 中多药耐药的共同机制。
Virulence. 2024 Dec;15(1):2367648. doi: 10.1080/21505594.2024.2367648. Epub 2024 Jun 20.
5
Whole genome global insight of antibiotic resistance gene repertoire and virulome of high - risk multidrug-resistant Uropathogenic Escherichiacoli.高风险多重耐药尿路致病性大肠埃希菌的抗生素耐药基因库和毒力组的全基因组全球洞察。
Microb Pathog. 2021 Dec;161(Pt A):105256. doi: 10.1016/j.micpath.2021.105256. Epub 2021 Oct 22.
6
Uropathogenic Escherichia coli in India-an Overview on Recent Research Advancements and Trends.印度的尿路致病性大肠杆菌——近期研究进展与趋势概述。
Appl Biochem Biotechnol. 2021 Jul;193(7):2267-2296. doi: 10.1007/s12010-021-03521-z. Epub 2021 Feb 17.
7
Reactive oxygen species and uspA overexpession: an alternative bacterial response toward selection and maintenance of multidrug resistance in clinical isolates of uropathogenic E. coli.活性氧物种和uspA 过表达:尿路致病性大肠杆菌临床分离株中多药耐药性选择和维持的一种替代细菌反应。
Eur J Clin Microbiol Infect Dis. 2020 Sep;39(9):1753-1760. doi: 10.1007/s10096-020-03903-x. Epub 2020 May 12.
8
Combination of bactericidal antibiotics and inhibitors of Universal stress protein A (UspA): a potential therapeutic alternative against multidrug resistant Escherichia coli in urinary tract infections.杀菌抗生素与普遍应激蛋白 A(UspA)抑制剂联合应用:治疗尿路感染中多重耐药大肠杆菌的潜在治疗选择。
J Antibiot (Tokyo). 2022 Jan;75(1):21-28. doi: 10.1038/s41429-021-00477-4. Epub 2021 Sep 15.
9
Phylogenetic group distributions, virulence factors and antimicrobial resistance properties of uropathogenic Escherichia coli strains isolated from patients with urinary tract infections in South Korea.从韩国尿路感染患者中分离出的尿路致病性大肠杆菌菌株的系统发育群分布、毒力因子及抗菌耐药特性
Lett Appl Microbiol. 2016 Jan;62(1):84-90. doi: 10.1111/lam.12517. Epub 2015 Dec 9.
10
Rapid Growth of Uropathogenic during Human Urinary Tract Infection.尿路致病性 在人体尿路感染中的快速生长。
mBio. 2018 Mar 6;9(2):e00186-18. doi: 10.1128/mBio.00186-18.

引用本文的文献

1
Beyond Infection: How Antimicrobial Therapies Influence the Urinary Microbiome and Stone Disease.超越感染:抗菌疗法如何影响泌尿微生物群和结石病
Pharmaceuticals (Basel). 2025 Jul 12;18(7):1038. doi: 10.3390/ph18071038.
2
Isolation, Identification, and Antibiotic Resistance, CRISPR System Analysis of from Forest Musk Deer in Western China.中国西部林麝的分离、鉴定、抗生素抗性及CRISPR系统分析
Microorganisms. 2025 Jul 17;13(7):1683. doi: 10.3390/microorganisms13071683.
3
Exploring Runs of Homozygosity and Heterozygosity in Sheep Breeds Maintained in Poland.

本文引用的文献

1
Prevalence of common carbapenemase genes and multidrug resistance among uropathogenic Escherichia coli phylogroup B2 isolates from outpatients in Wasit Province/ Iraq.伊拉克瓦西特省门诊患者中产肠杆菌科 B2 群中常见碳青霉烯酶基因和多重耐药的流行情况。
PLoS One. 2022 Jan 25;17(1):e0262984. doi: 10.1371/journal.pone.0262984. eCollection 2022.
2
Dictamnine Inhibits the Adhesion to and Invasion of Uropathogenic (UPEC) to Urothelial Cells.花椒毒素抑制尿路上皮细胞对尿路致病性大肠杆菌的黏附和侵袭。
Molecules. 2022 Jan 2;27(1):272. doi: 10.3390/molecules27010272.
3
Identification and characterization of class 1 integrons among multidrug-resistant uropathogenic Escherichia coli strains in Mexico.
探索波兰养殖绵羊品种中的纯合性和杂合性连续片段。
Genes (Basel). 2025 Jun 14;16(6):709. doi: 10.3390/genes16060709.
4
Cranberry constituents prevent SOS-mediated filamentation of uropathogenic .蔓越莓成分可防止尿致病性大肠杆菌由SOS介导的丝状体形成 。
Infect Immun. 2025 May 13;93(5):e0060024. doi: 10.1128/iai.00600-24. Epub 2025 Apr 10.
5
Geo-Temporal Variation in the Antimicrobial Resistance of in the Community.社区中抗菌药物耐药性的地理-时间变化。
Antibiotics (Basel). 2025 Feb 25;14(3):233. doi: 10.3390/antibiotics14030233.
6
A novel gene linked to Imipenem resistance in E. coli isolate lacking known Imipenem-resistance genes.在一株缺乏已知亚胺培南耐药基因的大肠杆菌分离株中,发现一个与亚胺培南耐药性相关的新基因。
Sci Rep. 2025 Mar 17;15(1):9065. doi: 10.1038/s41598-025-93587-0.
7
Prevalence and Zoonotic Risk of Multidrug-Resistant in Bovine Subclinical Mastitis Milk: Insights Into the Virulence and Antimicrobial Resistance.牛亚临床乳腺炎牛奶中多重耐药菌的流行情况及人畜共患病风险:对毒力和抗菌药物耐药性的见解
Food Sci Nutr. 2025 Jan 15;13(1):e4761. doi: 10.1002/fsn3.4761. eCollection 2025 Jan.
8
Antimicrobial resistance of Escherichia coli in cats and their drinking water: drug resistance profiles and antimicrobial-resistant genes.猫及其饮用水中大肠杆菌的抗菌耐药性:耐药谱和抗菌耐药基因
BMC Vet Res. 2024 Dec 20;20(1):573. doi: 10.1186/s12917-024-04435-8.
9
Targeting virulence of resistant Escherichia coli by the FDA-approved drugs sitagliptin and nitazoxanide as an alternative antimicrobial approach.将美国食品药品监督管理局(FDA)批准的药物西他列汀和硝唑尼特作为一种替代抗菌方法,靶向耐药性大肠杆菌的毒力。
Folia Microbiol (Praha). 2024 Oct 29. doi: 10.1007/s12223-024-01215-7.
10
UNAM-HIMFG Bacterial Lysate Activates the Immune Response and Inhibits Colonization of Bladder of Balb/c Mice Infected with the Uropathogenic CFT073 Strain.UNAM-HIMFG 细菌裂解物激活免疫反应并抑制感染尿道致病性 CFT073 菌株的 Balb/c 小鼠膀胱定植。
Int J Mol Sci. 2024 Sep 12;25(18):9876. doi: 10.3390/ijms25189876.
鉴定和表征墨西哥多重耐药尿路致病性大肠杆菌株中的 1 类整合子。
Microb Pathog. 2022 Jan;162:105348. doi: 10.1016/j.micpath.2021.105348. Epub 2021 Dec 3.
4
Molecular Epidemiology of Multidrug-Resistant Uropathogenic O25b Strains Associated with Complicated Urinary Tract Infection in Children.与儿童复杂性尿路感染相关的多重耐药尿路致病性O25b菌株的分子流行病学
Microorganisms. 2021 Nov 5;9(11):2299. doi: 10.3390/microorganisms9112299.
5
Whole genome global insight of antibiotic resistance gene repertoire and virulome of high - risk multidrug-resistant Uropathogenic Escherichiacoli.高风险多重耐药尿路致病性大肠埃希菌的抗生素耐药基因库和毒力组的全基因组全球洞察。
Microb Pathog. 2021 Dec;161(Pt A):105256. doi: 10.1016/j.micpath.2021.105256. Epub 2021 Oct 22.
6
Frequency of hlyA, hlyB, hlyC and hlyD genes in uropathogenic Escherichia coli isolated from UTI patients in Shiraz.从设拉子尿路感染患者中分离出的尿路致病性大肠杆菌中hlyA、hlyB、hlyC和hlyD基因的频率
GMS Hyg Infect Control. 2021 Aug 30;16:Doc25. doi: 10.3205/dgkh000396. eCollection 2021.
7
Combination of bactericidal antibiotics and inhibitors of Universal stress protein A (UspA): a potential therapeutic alternative against multidrug resistant Escherichia coli in urinary tract infections.杀菌抗生素与普遍应激蛋白 A(UspA)抑制剂联合应用:治疗尿路感染中多重耐药大肠杆菌的潜在治疗选择。
J Antibiot (Tokyo). 2022 Jan;75(1):21-28. doi: 10.1038/s41429-021-00477-4. Epub 2021 Sep 15.
8
Phenotypic and Genotypic Characteristics of Uropathogenic Isolates from Kenya.肯尼亚尿路致病性分离株的表型和基因型特征。
Microb Drug Resist. 2022 Jan;28(1):31-38. doi: 10.1089/mdr.2020.0432. Epub 2021 Jul 23.
9
IS Is Responsible for the Evolution and Transmission of -Harboring Plasmids in Escherichia coli of Poultry Origin in China.IS负责中国家禽源大肠杆菌中携带-的质粒的进化和传播。 (注:原文中“-Harboring”处似乎有信息缺失)
mSystems. 2021 Aug 31;6(4):e0064621. doi: 10.1128/mSystems.00646-21. Epub 2021 Jul 13.
10
There is no market for new antibiotics: this allows an open approach to research and development.新抗生素没有市场:这使得在研发方面可以采取开放的方法。
Wellcome Open Res. 2021 Jun 11;6:146. doi: 10.12688/wellcomeopenres.16847.1. eCollection 2021.